Morbidity and Mortality Weekly Report: Recommendations and Reports, March 10, 2023 / Vol. 72 / No. RR-1

Details

• Alternative Title:
  Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
• Personal Author:
  Conners, Erin E. ; Panagiotakopoulos, Lakshmi ; Hofmeister, Megan G. ; Spradling, Philip R. ; Hagan, Liesl M. ; Harris, Aaron M. ; Rogers-Brown, Jessica S. ; Wester, Carolyn ; Nelson, Noele P. ; Rapposelli, Karina ; Sandul, Amy L. ; Choi, Elisa ; Coffin, Carla ; Marks, Kristen ; Thomas, David L. ; Wang, Su H.
• Corporate Authors:
  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
• Description:
  Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality. Although treatment is not considered curative, antiviral treatment, monitoring, and liver cancer surveillance can reduce morbidity and mortality. Effective vaccines to prevent hepatitis B are available. This report updates and expands CDC's previously published Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection (MMWR Recomm Rep 2008;57[No. RR-8]) regarding screening for HBV infection in the United States. New recommendations include hepatitis B screening using three laboratory tests at least once during a lifetime for adults aged ≥18 years. The report also expands risk-based testing recommendations to include the following populations, activities, exposures, or conditions associated with increased risk for HBV infection: persons incarcerated or formerly incarcerated in a jail, prison, or other detention setting; persons with a history of sexually transmitted infections or multiple sex partners; and persons with a history of hepatitis C virus infection. In addition, to provide increased access to testing, anyone who requests HBV testing should receive it, regardless of disclosure of risk, because many persons might be reluctant to disclose stigmatizing risks.
• Subjects:
  Adolescent Adult Centers For Disease Control And Prevention, U.S. Hepatitis B Hepatitis B, Chronic Hepatitis B Virus Hepatitis C Humans Recommendations And Reports United States
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2023; v. 72, no. 1
• Series:
  Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.rr7201a1
• ISSN:
  1057-5987 (print) ; 1545-8601 (digital)
• Pubmed ID:
  36893044
• Pubmed Central ID:
  PMC9997714
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  28 pdf pages
• Volume:
  72
• Issue:
  1
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:c715c09bb9215bca3cf5a9221cdddc01ba99676025fc8dcba4cf816b0f59a8701837950d93e58d9d230e44cf7d6029829329617d66d9c57f379b6719c65e9f71
• Download URL:
  https://stacks.cdc.gov/view/cdc/169942/cdc_169942_DS1.pdf
• File Type:
  [PDF - 1002.96 KB ]